PropertyValue
?:abstract
  • In December 2019 in Wuhan, China the first cases of previously unknown, coronaviral infection-induced pneumonia have been reported. The new virus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) was named after SARS-CoV due to their similarities and the disease caused by the pathogen is COVID-19 (Coronavirus Disease 2019). On 11 March 2020 WHO (World Health Organization) defined the rapidly increasing number of incidents of COVID-19 as a pandemic. In this review we will present recent information about the SARS-CoV-2 focusing on the origin, clinical picture, diagnostic methods, structure, replication cycle of SARS-CoV-2 and potential pharmaceutical measures against COVID-19.
?:creator
?:doi
?:doi
  • 10.18388/pb.2020_321
?:journal
  • Postepy_biochemii
?:license
  • cc-by-sa
?:pmid
?:pmid
  • 32700510.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • Characteristics of SARS-CoV-2 and potential pharmacological treatment
?:type
?:year
  • 2020-05-09

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/xjt9ufbc>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/xjt9ufbc>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all